02/19/2025
4:02 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:17 PM | Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
Vera Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:18 PM | Eansor Norman David (Reporting)
Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:19 PM | Knobil Katharine (Reporting)
Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:20 PM | ELMS STEVE (Reporting)
Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:05 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form DEF 14A | |
02/04/2025
3:05 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form DEFA14A | |
01/20/2025
11:15 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form EFFECT | |
01/13/2025
3:05 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form PRE 14A | |
01/10/2025
4:09 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/30/2024
3:46 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
Get the Latest News and Ratings for MRKR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/23/2024
3:40 PM | BASKETT FOREST (Reporting)
Behbahani Ali (Reporting)
Chang Carmen (Reporting)
Florence Anthony A. Jr. (Reporting)
Makhzoumi Mohamad (Reporting)
Marker Therapeutics, Inc. (Issuer)
Marker Therapeutics (Issuer)
NEA 16 GP, LLC (Reporting)
NEA Partners 16, L.P. (Reporting)
New Enterprise Associates 16, L.P. (Reporting)
SANDELL SCOTT D (Reporting)
Walker Paul Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:30 PM | Marker Therapeutics, Inc. (Subject)
Marker Therapeutics (Subject)
New Enterprise Associates 16, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
12/23/2024
3:30 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
7:21 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
6:10 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2024
11:15 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form EFFECT | |
08/14/2024
3:47 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
3:39 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
6:12 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
5:25 PM | Marker Therapeutics, Inc. (Subject)
Marker Therapeutics (Subject)
New Enterprise Associates 16, L.P. (Filed by)
| Form SC 13D/A | |
05/15/2024
3:40 PM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
6:09 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
7:02 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:58 AM | Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
